2018
Serial intravascular ultrasound evaluation of the DESolve™ novolimus‐eluting bioresorbable coronary scaffold system
Barreira G, Costa J, Costa R, Staico R, Chamie D, Slhessarenko J, Tanajura L, Abizaid A, Sousa A, Abizaid A. Serial intravascular ultrasound evaluation of the DESolve™ novolimus‐eluting bioresorbable coronary scaffold system. Catheterization And Cardiovascular Interventions 2018, 92: e368-e374. PMID: 29521477, DOI: 10.1002/ccd.27591.Peer-Reviewed Original ResearchMeSH KeywordsAbsorbable ImplantsAgedCardiovascular AgentsCoated Materials, BiocompatibleCoronary AngiographyCoronary Artery DiseaseCoronary VesselsFemaleHumansMacrolidesMaleMiddle AgedPercutaneous Coronary InterventionPredictive Value of TestsProspective StudiesTime FactorsTreatment OutcomeUltrasonography, InterventionalConceptsBioresorbable coronary scaffoldsSafety of coronary angioplastySuppression of neointimal proliferationAdverse cardiac eventsTime pointsLate lumen lossNon-randomized studiesPercutaneous coronary interventionDevice dimensionsIntravascular ultrasound evaluationScaffold systemConsecutive patientsCoronary scaffoldsPrimary endpointSingle-centerCardiac eventsAngiographic successUltrasound evaluationFollow-upLumen lossCoronary interventionSerial evaluationNeointimal proliferationScaffold areaCoronary angioplasty
2017
The Mirage microfiber sirolimus eluting coronary scaffold
Santoso T, Bang L, Costa R, Chamié D, Su S, Abizaid A, Onuma Y, Serruys P. The Mirage microfiber sirolimus eluting coronary scaffold. 2017, 316-318. DOI: 10.1201/9781315380629-36.Peer-Reviewed Original Research
2013
Prospective, multi-center evaluation of the desolve NX novolimus-eluting bioresorbable coronary scaffold: principal clinical and imaging endpoints
Abizaid A, Schofer J, Meng M, Witzenbichler B, Bothelho R, Costa J, Chamie D, Medical I, Ormiston J, Verheye S. Prospective, multi-center evaluation of the desolve NX novolimus-eluting bioresorbable coronary scaffold: principal clinical and imaging endpoints. European Heart Journal 2013, 34: p5547. DOI: 10.1093/eurheartj/eht310.p5547.Peer-Reviewed Original ResearchMajor adverse cardiac eventsCoronary scaffoldsBioresorbable coronary scaffoldsCoronary artery lesionsPercutaneous coronary interventionProcedural successClinical endpointsPolylactide-based polymersVascular scaffoldsArtery lesionsBioresorbable vascular scaffoldComposite endpoint of cardiac deathAnnually to 5 yearsEndpoint of cardiac deathMultiple clinical endpointsDe novo coronary artery lesionsDrug-eluting bioresorbable vascular scaffoldsAdverse cardiac eventsLong-term scaffoldTarget lesion revascularizationNative coronary artery lesionsTarget vessel revascularizationMultiple imaging modalitiesTarget vessel MIOCT assessment
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply